reSET
The newly released PDTs, now RESET and RESET-O, deliver a self-directed, 12-week course of cognitive behavioral therapy that incentivizes patients to conform to treatment.
The Wisconsin Department of Health Services plans to make reSET and reSET-O available through providers in outpatient settings.
The first telehealth offering included in the program is PursueCare, which focuses on addiction medicine.
The company currently has three prescription digital therapeutics available on the market.
The pharma's Sandoz division will be handing commercialization of reSET, reSET-O and future therapies back to Pear over the course of a transition period.
Also: The pharma industry continues to use digital technologies for R&D and diabetes management.
A new innovation center called the Biome and numerous internal efforts paint a picture of a digital-focused game plan.
As the first prescription digital therapeutic approved by the FDA, the treatment will be distributed and supported by a specialist-staffed service center.